A comparative evaluation of the antimicrobial activity of local antiseptics in revision hip arthroplasty.

A. E. Loskutov, A. V. Digtiar, D. A. Stepanskiy

Abstract


In our study there is presented information on the research of antagonistic activity of medications octenidine, decamethoxine, dioxydine, myramistin, povidone-iodine, chlorhexidine in standard dosage form and in dilution (1:1 and 1:5) on microorganisms: S. aureus, S. epidermidis, S. haemolitycus, P. aeruginоsa, E. agglomerans, E. coli isolated from patients in revision hip arthroplasty. A considerable bacrteriostatic and bacreticidal activity of investigated medications on microorganisms was shown. The investigation of antagonistic activity of medications was conducted by the “well” method according to methodological guidelines for experimental (pre-clinical) investigation of medicinal productsfor local treatment of purulent wounds. As a solid nutrient solution there was used Mueller-Hinton agar, in which we made cavities with diameter of 8 mm where experimental medications (0,01 ml) were put. As experimental test-cultures there were used main clinical strains of microorganisms (S. aureus, S. epidermidis, S. haemolitycus, P. aeruginоsa, E. agglomerans, E. coli) isolated from patients, receiving treatment in the department of orthopaedics N 2, I.I. Mechnikov regional clinical hospital. 0.9% physiologic saline was used as a control. Chlorhexidine, octenidine, dioxydine, decamethoxine and povidone-iodine undiluted and in dilution 1:1, causebactericidal effect on staphylococcus, in dilution 1:5 – bacteriostatic effect. Myramistin has practically no effect on staphylococcus. Dioxydine and octenidine in initial dilution have a steady bactericidal effect on E. coli and P. aeruginosa and in dilution 1:1 only dioxydine has bactericidal effect. Chlorhexidine and povidone-iodine have bacteriostatic effect on E.coli and P. aeruginosa. In dilution 1:5 only dioxydine has a bactericidal effect on E. coli and P. aeruginosa. For E. agglomerans only dioxydine in standard dosage form and in dilution 1:1 and 1:5 has bactericidal effect 36mm, 33mm and 25 mm accordingly. But octenidine in a standard dosage form has bactericidal effect on E. agglomerans and in dilution 1:1 – bacteriostatic. Other medications have no effect on E. agglomerans. Antimicrobal effect in a standard dosage form on the greatest amount of experimental microorganisms strains wasin octenidine and dioxydine; in dilution 1:1 – in octenidine and dioxydine on enterobacteria, on staphylococci – chlorhexidine, octenidine and dioxydine; in dilution 1:5 – the maximal effect on enterobacteria was in dioxydine and on staphylococci in chlorhexidine.


Keywords


antiseptic; antimicrobial activity; revision hip replacement

Full Text:

PDF

References


1. Vorontsova TN. [Socio-biological and clinical diagnostic characteristics of patients undergoing revision hip arthroplasty (according to the materials of the Federal register endoprosthesis replacement of large joints of the limbs)]. Endoprosthesis in Russia: vseros. SB. nauch. articles. Kazan, St. Petersburg, 2005;l(1):253-8. Russian.

2. Loskutov AE. [Total hip Arthroplasty: a Mono­graph under the editorship of Professor A.E. Loskutov]. Dnepropetrovsk: Lira, 2010;344. Russian.

3. Tykhylov RM. [Guide to total hip arthroplasty, ed. by R.M. Tikhilov, V.M. Shapovalov]. SPb.: RNIITO them. R.R. Vreden, 2008;324. Russian.

4. Khabriev RU. Guidance on experimental (pre­clinical) study of new pharmacological substances]. Mos­kva, 2005;832. Russian.

5. Danish Hip Arthroplasty Register. Annual Report 2004. Available from: URL:http://www.dhr.dk.

6. Della Valle CJ, Paprosky WG. The femur in revision total hip arthroplasty: evaluation and clas­sification. Clin. Orthop. 2004;420:55-62.

7. Eryukhin IA. Problems of peritonitis and ab­dominal sepsis. Consilium Medicum. 2005;7(6):468-72.

8. Fevang BT, et al. Improved results of primary total hip replacement. Acta Orthop. 2010;81(6):649-59.

9. Flugsrud GB, et al. Risk factors for total hip replacement due to primary osteoarthritis: a cohort study in 50,034 persons. Arthritis Rheum. 2002;46(3):675-82.

10. Lorio R, et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J. Bone Joint Surg. 2008;90-A(7):1598-605.

11. Mangram AJ, Horan TC, Pearson ML. Guideline for Prevention of Surgical Site Infection Infect. Control. Hosp. Epidemiol. 1999;20(4):250-78.

12. National Joint Registry for England, Wales and Northern Ireland. 10th Annual Report 2013. Available from: URL:http://www.njrcenter.org.uk.

13. National Joint Registry for England, Wales and Northern Ireland. 8th Annual Report 2010. Available from: URL:http://www.njrcenter.org.uk.


GOST Style Citations


  1. Воронцова Т.Н. Социально-биологическая и клинико-диагностическая характеристика пациентов, перенесших ревизионное эндопротезирование тазо­бедренного сустава (по материалам Федерального регистра эндопротезирования крупных суставов конечностей) / Т.Н. Воронцова // Эндопротезирование в России: всерос. сб. науч. статей. – Казань, СПб., 2005. – Вып. 1. – С. 253–258
  2. Лоскутов А.Е. Эндопротезирование тазо­бед­ренного сустава: монография / под ред. проф. А.Е. Лоскутова. – Днепропетровск: Лира, 2010. – 344с.
  3. Тихилов Р.М. Руководство по эндопротезиро­ванию тазобедренного сустава / под ред. Р.М. Ти­хилова, В.М. Шаповалова. – СПб.: РНИИТО им. Р.Р. Вредена, 2008. - 324 с.
  4. Хабриев Р.У. Руководство по эксперименталь­но­му (доклиническому) изучению новых фармаколо­ги­ческих веществ / Р.У. Хабриев. – Москва, 2005. – 832 с.
  5. Danish Hip Arthroplasty Register. Annual Report 2004. Available from: URL:http://www.dhr.dk.
  6. Della Valle C.J. The femur in revision total hip arthroplasty evaluation and classification / C.J. Della Val­le, W.G. Paprosky // Clin. Orthop. – 2004. – Vol. 420. – P. 55–62.
  7. Eryukhin I.A. Problems of peritonitis and abdo­minal sepsis/ I.A. Eryukhin Consilium Medicum.- 2005.- Vol. 7, N 6.- P.468 – 472.
  8. Fevang B.T. Improved results of primary total hip replacement / B.T. Fevang // Acta Orthop. – 2010. – Vol. 81, N 6. – P. 649–659.
  9. Flugsrud G.B. Risk factors for total hip rep­lacement due to primary osteoarthritis: a cohort study in 50,034 persons / G.B. Flugsrud // Arthritis Rheum. – 2002. – Vol. 46, N 3. – P. 675–682.
  10.  Lorio R. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in theUnited States: preparing for an epidemic / R. Lorio // J. Bone Joint Surg. – 2008. – Vol. 90-A, N 7. – P. 1598–605.
  11. Mangram A.J. Guideline for Prevention of Sur­gical Site Infection Infect / A.J. Mangram, T.C. Horan, M.L. Pearson // Control. Hosp. Epidemiol. - 1999. - Vol. 20, N 4.- P. 250–278.
  12. National Joint Registry for England, Walesand Northern Ireland. 10th Annual Report 2013. Available from: URL:http://www.njrcenter.org.uk.
  13. National Joint Registry for England, Walesand Northern Ireland. 8th Annual Report 2010. Available from: URL:http://www.njrcenter.org.uk


Refbacks

  • There are currently no refbacks.